Alk-Abello AS (CHIX:ALKBC) Inventories, Finished Goods: kr0 Mil (As of Mar. 2026)


CHIX:ALKBC Alk-Abello AS CHIX:ALKBC
93 GF Score
Price kr256.30
GF Value kr207.52
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Alk-Abello AS Inventories, Finished Goods?

Alk-Abello AS CHIX:ALKBC 93 Inventories, Finished Goods is kr0 Mil as of Mar. 2026. GuruFocus rates CHIX:ALKBC with a GF Score™ of 93/100 and a GF Value™ of kr207.52 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Alk-Abello AS's quarterly finished goods increased from Sep. 2025 (kr0 Mil) to Dec. 2025 (kr680 Mil) but then declined from Dec. 2025 (kr680 Mil) to Mar. 2026 (kr0 Mil).

Alk-Abello AS's annual finished goods increased from Dec. 2023 (kr479 Mil) to Dec. 2024 (kr662 Mil) and increased from Dec. 2024 (kr662 Mil) to Dec. 2025 (kr680 Mil).

Alk-Abello AS Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Inventories, Finished Goods Chart

Alk-Abello AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 527.00 525.00 479.00 662.00 680.00

Alk-Abello AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 680.00 0.00
CHIX:ALKBC
93GF Score
Alk-Abello AS CHIX:ALKBC
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of kr0 Mil mean?
Alk-Abello AS (CHIX:ALKBC) has a Inventories, Finished Goods of kr0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Alk-Abello AS and its competitors.
Is Alk-Abello AS's Inventories, Finished Goods too high?
Alk-Abello AS's current Inventories, Finished Goods is kr0 Mil. Overall, Alk-Abello AS has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Inventories, Finished Goods compare to VRTX and REGN?
Alk-Abello AS's Inventories, Finished Goods of kr0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Inventories, Finished Goods is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (CHIX:ALKBC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr207.52, compared to a current price of kr256.30 — trading 23.5% above its estimated fair value. The current Inventories, Finished Goods is kr0 Mil. Alk-Abello AS's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Alk-Abello AS (CHIX:ALKBC), the current Inventories, Finished Goods is kr0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of kr256.30 is trading 23.5% above its estimated GF Value™ of kr207.52. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for CHIX:ALKBC:

  • Inventories, Finished Goods: kr0 Mil
  • GF Value™: kr207.52 vs. price of kr256.30 (23.5% above fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
93GF Score

Get the complete analysis for CHIX:ALKBC

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr256.30
Price
kr207.52
GF Value